Please use this identifier to cite or link to this item: https://doi.org/10.1038/mt.2009.22
Title: High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment
Authors: Balani, P.
Boulaire, J.
Zhao, Y.
Zeng, J.
Lin, J.
Wang, S. 
Issue Date: 2009
Citation: Balani, P., Boulaire, J., Zhao, Y., Zeng, J., Lin, J., Wang, S. (2009). High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment. Molecular Therapy 17 (6) : 1003-1011. ScholarBank@NUS Repository. https://doi.org/10.1038/mt.2009.22
Abstract: Achievement of specific tumor cell targeting remains a challenge for glioma gene therapy. We observed that the human high mobility group box2 (HMGB2) gene had a low level of expression in normal human brain tissues, but was significantly upregulated in glioblastoma tissues. With progressive truncation of a 5′-upstream sequence of the HMGB2 gene, we identified a 0.5-kb fragment displaying a high transcriptional activity in glioblastoma cells, but a low activity in normal brain cells. To test the feasibility of using the HMGB2 promoter sequence in targeted cancer therapy, we constructed a baculoviral vector expressing the herpes simplex virus thymidine kinase (HSVtk) gene driven by the HMGB2 promoter. Transduction with the viral vector induced cell death in glioblastoma cell lines in the presence of ganciclovir (GCV), but did not affect the survival of human astrocytes and neurons. In a mouse xenograft model, intratumor injection of the baculoviral vector suppressed the growth of human glioblastoma cells and prolonged the survival of tumor-bearing mice. Our results suggest that the novel 5′ sequence of HMGB2 gene has a potential to be used as an efficient, tumor-selective promoter in targeted vectors for glioblastoma gene therapy.
Source Title: Molecular Therapy
URI: http://scholarbank.nus.edu.sg/handle/10635/100828
ISSN: 15250016
DOI: 10.1038/mt.2009.22
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

38
checked on Sep 30, 2022

WEB OF SCIENCETM
Citations

34
checked on Sep 30, 2022

Page view(s)

134
checked on Sep 22, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.